Low Plasma Choline, High Trimethylamine Oxide, and Altered Phosphatidylcholine Subspecies Are Prevalent in Cystic Fibrosis Patients with Pancreatic Insufficiency
Nutrients · 2025
DOI: 10.3390/nu17050868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Wolfgang Bernhard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Children's Hospital, University Clinic, 72076 Tübingen, Germany. Hauptthemen laut MEDLINE: Cystic Fibrosis, Methylamines, Choline, Phosphatidylcholines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Exocrine pancreatic insufficiency in cystic fibrosis (CF) increases fecal choline losses, but the postnatal course of plasma choline and its metabolites in these patients is unknown. While choline homeostasis is crucial for cellular, bile, and lipoprotein metabolism, via phosphatidylcholine (PC) and via betaine as a methyl donor, choline deficiency is associated with impaired lung and liver function, including hepatic steatosis.
Objective
The goal of our study was to evaluate the plasma levels of choline, betaine, trimethylamine oxide (TMAO), PC, and PC subclasses in CF patients from infancy to adulthood and compare those with exocrine pancreatic insufficiency (EPI) to those with pancreatic sufficiency (EPS).
Methods
Retrospective analysis of target parameters in plasma samples (July 2015–November 2023) of CF patients (0.64–24.6 years) with tandem mass spectrometry.
Results
A total of 477 samples from 162 CF patients were analyzed. In CF patients with EPI (N = 148), plasma choline and betaine concentrations were lower and decreased with age compared to EPS patients showing normal values. TMAO concentrations, indicating intestinal choline degradation by bacterial colonization, were frequently elevated in EPI from infancy onwards, and inversely related to plasma choline and betaine levels. PC-containing linoleic acid levels were lower in EPI, but arachidonic and docosahexaenoic acid content was similar in both patient groups.
Conclusion
CF patients with EPI are at risk of choline and betaine deficiency compared to exocrine pancreas-sufficient CF patients. Elevated TMAO concentrations in EPI patients indicate increased bacterial colonization leading to choline degradation before absorption. These findings indicate that laboratory testing of choline, betaine, and TMAO as well as clinical trials on choline supplementation are warranted in CF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Children's Hospital, University Clinic, 72076 Tübingen, Germany.
- General Pediatrics, Hematology & Oncology, Children's Hospital, University Clinic, 72076 Tübingen, Germany.
- Department of Pediatric Gastroenterology and Hepatology, Children's Hospital, University Clinic, 72076 Tübingen, Germany.
ORCID-Profile: Wolfgang Bernhard, Johannes Hilberath
Zitieren
APA
Bernhard, W., Shunova, A., Boriga, J., Graepler-Mainka, U., & Hilberath, J. (2025). Low Plasma Choline, High Trimethylamine Oxide, and Altered Phosphatidylcholine Subspecies Are Prevalent in Cystic Fibrosis Patients with Pancreatic Insufficiency. Nutrients. https://doi.org/10.3390/nu17050868
Vancouver
Bernhard W, Shunova A, Boriga J, Graepler-Mainka U, Hilberath J. Low Plasma Choline, High Trimethylamine Oxide, and Altered Phosphatidylcholine Subspecies Are Prevalent in Cystic Fibrosis Patients with Pancreatic Insufficiency. Nutrients. 2025. doi:10.3390/nu17050868
BibTeX
@article{Bernhard2025,
author = {Bernhard, Wolfgang and Shunova, Anna and Boriga, Julia and Graepler-Mainka, Ute and Hilberath, Johannes},
title = {Low Plasma Choline, High Trimethylamine Oxide, and Altered Phosphatidylcholine Subspecies Are Prevalent in Cystic Fibrosis Patients with Pancreatic Insufficiency},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17050868}
}
EUVIMED